Position in HIMS
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$11,441
+$11,026 QoQ
Shares Held
330
+1550.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#426
of 504 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CoreCap Advisors, LLC holds $246,750 across 19 Drug Manufacturers - Specialty & Generic names. HIMS ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
3,967 | $62,995 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
2,420 | $59,556 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
85 | $46,055 | |
| 4 | ZTS |
Zoetis Inc.
|
439 | $31,546 | |
| 5 | HLN |
Haleon plc
|
1,408 | $13,136 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
This page
|
330 | $11,441 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
64 | $10,786 | |
| 8 | CRON |
Cronos Group Inc.
|
1,000 | $2,780 |
All Filings in HIMS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,441 | 330 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $415 | 20 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $649 | 20 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $139,928 | 2,467 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $519,686 | 10,425 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,775 | 500 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $3,578 | 148 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $782,223 | 42,466 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||